Efficacy and Safety of Deucravacitinib Versus Placebo in Participants With Moderate-to-severe Scalp Psoriasis
Clinical trial NCT05478499 · COMPLETED
Trial details
- NCT number
- NCT05478499
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-06
- Primary completion
- 2024-01-11
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.